Overexpression of CD39/nucleoside triphosphate diphosphohydrolase-1 decreases smooth muscle cell proliferation and prevents neointima formation after angioplasty.
about
In vitro Study of a Novel Stent Coating Using Modified CD39 Messenger RNA to Potentially Reduce Stent Angioplasty-Associated Complications.P2X(1) receptor inhibition and soluble CD39 administration as novel approaches to widen the cardiovascular therapeutic windowSuppression of endothelial CD39/ENTPD1 is associated with pulmonary vascular remodeling in pulmonary arterial hypertension.Involvement of P2Y12 receptor in vascular smooth muscle inflammatory changes via MCP-1 upregulation and monocyte adhesion.Vascular smooth muscle cell expression of ectonucleotidase CD39 (ENTPD1) is required for neointimal formation in mice.
P2860
Overexpression of CD39/nucleoside triphosphate diphosphohydrolase-1 decreases smooth muscle cell proliferation and prevents neointima formation after angioplasty.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Overexpression of CD39/nucleos ...... a formation after angioplasty.
@en
type
label
Overexpression of CD39/nucleos ...... a formation after angioplasty.
@en
prefLabel
Overexpression of CD39/nucleos ...... a formation after angioplasty.
@en
P2093
P2860
P1476
Overexpression of CD39/nucleos ...... ma formation after angioplasty
@en
P2093
E Csizmadia
E Kaczmarek
M Bojakowska
S C Robson
P2860
P304
P356
10.1111/J.1538-7836.2008.03019.X
P577
2008-07-01T00:00:00Z